A meta-analysis included five randomized controlled studies of 285 patients with PCOS and IR found that there was no statistically significant difference between the BUSHEN HUATAN group and the metformin group in improving LH, FSH, fasting blood glucose, and fasting insulin (Huang et al., 2020). This evidence concerns the gene BRD2 and polycystic ovary syndrome.